Navigation Links
Biotel Announces Record Revenues and Strong Earnings for the Fourth Quarter and Year Ended June 30, 2007
Date:10/1/2007

MINNEAPOLIS, Oct. 1 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL) announced record sales and strong earnings for both its fourth quarter and fiscal year ended June 30, 2007. The Company had net earnings of $220,780, or $0.07 per diluted share, in the fourth quarter on revenues of $3,114,791. This compares to net earnings of $26,628, or $0.01 per diluted share, on revenues of $2,734,911 for the fourth quarter of last year. Net earnings for the year ended June 30, 2007, were $519,733, or $0.19 per diluted share, on revenues of $11,233,397. This compares to net earnings of $452,225, or $0.16 per diluted share, on revenues of $10,223,332 last year.

Highlights for the quarter and year are as follows:

-- Fifth consecutive year of profitability

-- 15.0% net income growth for year

-- 9.9% revenue growth for year; 13.9% for Q4

-- Net cash of $1.4 million provided from operations in fiscal year

-- Strong balance sheet with long-term debt reduced to zero from $620,000

last year

-- Stockholders' equity of $3,932,500, up 18.7% for fiscal year

"We closed a strong fiscal year with a very strong fourth quarter, as a result of growth in our product and service revenues and improved margins," Biotel President and CEO Steve Springrose said. "We experienced steadily increasing sales of our Braemar cardiac event recorders, Holter devices, liposuction and other medical devices. Revenues from our Agility 24/7 cardiac monitoring services for clinical research continued to grow rapidly. Biotel is successfully implementing its strategy of serving as a development partner to medical corporations seeking new devices and clinical research services."

In fiscal 2007, Biotel increased research and development expenditures by $243,000 to almost $1.5 million, or 13 percent of revenues. "We continued our focus on proprietary technology at Biotel through significant R&D programs," Springrose commented. "This has enabled us to introduce the Braemar ER900L, expanding our line of event monitors, and to develop the next generation of Braemar Holter cardiac recording devices, which we are preparing to launch. More importantly, we are positioning Biotel to compete effectively in the dawning era of wireless cardiac monitoring with innovative, state-of-the-art products and service offerings."

3 months ended 3 months ended %

June 30, 2007 June 30, 2006 Change

Revenues $3,115,000 $2,735,000 + 13.9 %

Net Income $221,000 $27,000 + 718.5 %

Earnings Per Share, Basic $0.08 $0.01

Earnings Per Share, Diluted $0.08 $0.01

12 months ended 12 months ended %

June 30, 2007 June 30, 2006 Change

Revenues $11,234,000 $10,223,000 +9.9%

Net Income $520,000 $452,000 +15.0%

Earnings Per Share, Basic $0.20 $0.17

Earnings Per Share, Diluted $0.19 $0.16


'/>"/>
SOURCE Biotel Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: